UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer: An Updated Systematic Review (2001―2009)

JNCI : Journal of the National Cancer Institute, 2011-02, Vol.103 (3), p.178-231

2011

Volltextzugriff (PDF)

Selecting a BRCA risk assessment model for use in a familial cancer clinic

BMC medical genetics, 2008-12, Vol.9 (1), p.116-116, Article 116

2008

Volltextzugriff (PDF)

Multicenter, Randomized, Cross-Over Clinical Trial of Venlafaxine Versus Gabapentin for the Management of Hot Flashes in Breast Cancer Survivors

Journal of clinical oncology, 2010-12, Vol.28 (35), p.5147-5152

2010

Volltextzugriff (PDF)

Changes in Estrogen Receptor, Progesterone Receptor and Her-2/neu Status with Time: Discordance Rates Between Primary and Metastatic Breast Cancer

Anticancer research, 2009-05, Vol.29 (5), p.1557-1562

2009

Volltextzugriff (PDF)

An international mixed methods study to develop a new preference-based measure for women with breast cancer: the BREAST-Q Utility module

BMC women's health, 2021-01, Vol.21 (1), p.8-8, Article 8

2021

Volltextzugriff (PDF)

Iterative qualitative approach to establishing content validation of a patient-reported outcome measure for arm lymphedema: the LYMPH-Q Upper Extremity Module

Journal of patient-reported outcomes, 2024-06, Vol.8 (1), p.63-10, Article 63

2024

Volltextzugriff (PDF)

Re-examining content validity of the BREAST-Q more than a decade later to determine relevance and comprehensiveness

Journal of patient-reported outcomes, 2023-04, Vol.7 (1), p.37-37, Article 37

2023

Volltextzugriff (PDF)

Health-Related Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer—Taking Stock

JNCI : Journal of the National Cancer Institute, 2003-02, Vol.95 (4), p.263-281

2003

Volltextzugriff (PDF)

Three methods for minimally important difference: no relationship was found with the net proportion of patients improving

Journal of clinical epidemiology, 2007-05, Vol.60 (5), p.448-455

2007

Volltextzugriff (PDF)

Detection of Macrotroponin in Patients Receiving Treatment for Breast Cancer

CJC open (Online), 2023-08, Vol.5 (8), p.658-660

2023

Volltextzugriff (PDF)

The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations

Hereditary cancer in clinical practice, 2024-05, Vol.22 (1), p.7-7, Article 7

2024

Volltextzugriff (PDF)

Therapeutic options for the management of hot flashes in breast cancer survivors: An evidence-based review

Clinical therapeutics, 2007-02, Vol.29 (2), p.230-241

2007

Volltextzugriff (PDF)

Health-Related Quality of Life and Psychosocial Status in Breast Cancer Prognosis: Analysis of Multiple Variables

Journal of clinical oncology, 2004-10, Vol.22 (20), p.4184-4192

2004

Volltextzugriff (PDF)

Identification of Cancer Care and Protocol Characteristics Associated With Recruitment in Breast Cancer Clinical Trials

Journal of clinical oncology, 2008-09, Vol.26 (27), p.4458-4465

2008

Volltextzugriff (PDF)

Evaluation of a novel strategy to implement exercise evidence into clinical practice in breast cancer care: protocol for the NEXT-BRCA randomised controlled trial

BMJ Open Sport & Exercise Medicine, 2020, Vol.6 (1), p.e000922

2020

Volltextzugriff (PDF)

Quality of Life in a Randomized Trial of Group Psychosocial Support in Metastatic Breast Cancer: Overall Effects of the Intervention and an Exploration of Missing Data

Journal of clinical oncology, 2003-05, Vol.21 (10), p.1944-1951

2003

Volltextzugriff (PDF)

International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation

British journal of cancer, 2019-07, Vol.121 (1), p.15-21

2019

Volltextzugriff (PDF)

Responsiveness to Change to Change Due to Supportive-Expressive Group Therapy, Improvement in Mood and Disease Progression in Women with Metastatic Breast Cancer

Quality of life research, 2007-08, Vol.16 (6), p.1007-1017

2007

Volltextzugriff (PDF)

Development and Psychometric Validation of the BREAST-Q Sensation Module for Women Undergoing Post-Mastectomy Breast Reconstruction

Annals of surgical oncology, 2021-11, Vol.28 (12), p.7842-7853

2021

Volltextzugriff (PDF)

Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario

Journal of clinical oncology, 2016-04, Vol.34 (10), p.1065-1071

2016

Volltextzugriff (PDF)

Adjuvant Chemotherapy for Breast Cancer in a Patient with Primary Autoimmune Neutropenia

Breast Cancer: Basic and Clinical Research, 2013-01, Vol.2013 (2013), p.1-6

2013

Volltextzugriff (PDF)

Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab

The oncologist (Dayton, Ohio), 2023-09, Vol.28 (9), p.e712-e722

2023

Volltextzugriff (PDF)

A Systematic Literature Review of Health Utility Values in Breast Cancer

Medical Decision Making, 2022-07, Vol.42 (5), p.704-719

2022

Volltextzugriff (PDF)

Development and Psychometric Validation of the BREAST-Q Animation Deformity Scale for Women Undergoing an Implant-Based Breast Reconstruction After Mastectomy

Annals of surgical oncology, 2021-09, Vol.28 (9), p.5183-5193

2021

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Englisch
(106)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer: An Updated Systematic Review (2001―2009)

Selecting a BRCA risk assessment model for use in a familial cancer clinic

Multicenter, Randomized, Cross-Over Clinical Trial of Venlafaxine Versus Gabapentin for the Management of Hot Flashes in Breast Cancer Survivors

Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial

Changes in Estrogen Receptor, Progesterone Receptor and Her-2/neu Status with Time: Discordance Rates Between Primary and Metastatic Breast Cancer

An international mixed methods study to develop a new preference-based measure for women with breast cancer: the BREAST-Q Utility module

Iterative qualitative approach to establishing content validation of a patient-reported outcome measure for arm lymphedema: the LYMPH-Q Upper Extremity Module

Re-examining content validity of the BREAST-Q more than a decade later to determine relevance and comprehensiveness

Health-Related Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer—Taking Stock

Three methods for minimally important difference: no relationship was found with the net proportion of patients improving

Detection of Macrotroponin in Patients Receiving Treatment for Breast Cancer

The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations

Therapeutic options for the management of hot flashes in breast cancer survivors: An evidence-based review

Health-Related Quality of Life and Psychosocial Status in Breast Cancer Prognosis: Analysis of Multiple Variables

Identification of Cancer Care and Protocol Characteristics Associated With Recruitment in Breast Cancer Clinical Trials

Evaluation of a novel strategy to implement exercise evidence into clinical practice in breast cancer care: protocol for the NEXT-BRCA randomised controlled trial

Quality of Life in a Randomized Trial of Group Psychosocial Support in Metastatic Breast Cancer: Overall Effects of the Intervention and an Exploration of Missing Data

International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation

Responsiveness to Change to Change Due to Supportive-Expressive Group Therapy, Improvement in Mood and Disease Progression in Women with Metastatic Breast Cancer

Development and Psychometric Validation of the BREAST-Q Sensation Module for Women Undergoing Post-Mastectomy Breast Reconstruction

Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario

Adjuvant Chemotherapy for Breast Cancer in a Patient with Primary Autoimmune Neutropenia

Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab

A Systematic Literature Review of Health Utility Values in Breast Cancer

Development and Psychometric Validation of the BREAST-Q Animation Deformity Scale for Women Undergoing an Implant-Based Breast Reconstruction After Mastectomy

Suchergebnisse filtern